• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

FDA:GR

29.650 EUR 0.519 1.78%

As of 13:55:06 ET on 08/29/2014.

Snapshot for Akorn Inc (FDA)

Open: 29.440 Day's Range: 29.075 - 29.785 Volume: 0
Previous Close: 29.131 52wk Range: 13.220 - 30.206 1-Yr Rtn: +119.79%

Stock Chart for FDA

No chart data available.
  • FDA:GR 29.650
  • 1D
  • 1M
  • 1Y
29.131
Interactive FDA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for FDA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 38.8971
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 1.0020
Est. PEG Ratio 1.2289
Market Cap (M EUR) 3,087.56
Shares Outstanding (M) 104.13
30 Day Average Volume 90
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for FDA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for FDA

Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties.

Rajat Rai "Raj"Chief Executive OfficerTimothy A Dick "Tom"CFO/Investor Relations
Bruce KutinskyChief Operating OfficerMark M SilverbergExec VP: Quality Assurance
More Company Profile & Key Executives for FDA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil